Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study (Q73580673)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12829139%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12829139%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

Xiang Gao

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12829139%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Susan G Fisher

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12829139%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Bahman Emami

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12829139%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

English

0 references

publication date

1 July 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12829139%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Radiation Oncology Biology Physics

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12829139%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12829139%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12829139%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

1038-1045

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12829139%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

cites work

Cancer statistics, 2003.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Risk of breast cancer following low-dose radiation exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Frequent chest X-ray fluoroscopy and breast cancer incidence among tuberculosis patients in Massachusetts.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Breast cancer among radiologic technologists

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Breast cancer and other second neoplasms after childhood Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Mortality from breast cancer after irradiation during fluoroscopic examinations in patients being treated for tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Radiation-associated breast cancer after Hodgkin's disease: risks and screening in perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Risk factors predicting the incidence of second primary breast cancer among women diagnosed with a first primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Contralateral breast cancer: annual incidence and risk parameters.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Breast cancer. Experiences with conservation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Local relapse and contralateral tumor rates in patients with breast cancer treated with conservative surgery and radiotherapy (institut gustave roussy 1970–1982)

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Contralateral breast cancer and other second malignancies in patients treated by breast-conserving therapy with radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Conservation surgery and radiation therapy in the treatment of operable breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Breast relapse following primary radiation therapy for early breast cancer. I. Classification, frequency and salvage.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Conservative management of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Second cancers after conservative surgery and radiation for stages I-II breast cancer: identifying a subset of women at increased risk

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Prognostic factors for metachronous contralateral breast cancer: a comparison of the linear Cox regression model and its artificial neural network extension.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Adjuvant radiotherapy and risk of contralateral breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Cancer in the contralateral breast after radiotherapy for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

A population-based study of contralateral breast cancer following a first primary breast cancer (Washington, United States)

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Risk of contralateral breast cancer. Associations with histologic, clinical, and therapeutic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Contralateral breast cancers following treatment for initial breast cancers in women

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Risk of contralateral breast cancer in Denmark 1943-80.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Risk of contralateral breast cancer among women with carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Consecutive primary carcinomas of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

BILATERAL PRIMARY BREAST CANCER; A PROSPECTIVE CLINICOPATHOLOGICAL STUDY.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Differences in breast cancer prognosis among African-American and Caucasian women

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Racial differences in breast carcinoma survival

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Dose to the contralateral breast due to primary breast irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Scatter dose from tangential breast irradiation to the uninvolved breast

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Comparison of contralateral breast doses from 1/2 beam block and isocentric treatment techniques for patients treated with primary breast irradiation with 60CO.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Radiation therapy of breast carcinoma: confirmation of prescription dose using diodes

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

A mono isocentric technique for breast and regional nodal therapy using dual asymmetric jaws

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Dose to contralateral breast: a comparison of four primary breast irradiation techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

A comparison of different intensity modulation treatment techniques for tangential breast irradiation.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Intensity-modulated tangential beam irradiation of the intact breast.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Radiation dose and second breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Breast conservation is the treatment of choice in small breast cancer: long-term results of a randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900203-7

7 January 2021

10.1016/S0360-3016(03)00203-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12829139%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference